About Imidex
Imidex was a healthcare AI company focused on developing computer vision and artificial intelligence solutions specifically for medical imaging, with a primary emphasis on early lung cancer detection. Their flagship product, VisiRad XR, was an FDA 510(k)-cleared AI software designed to assist radiologists in identifying potential lung nodules and masses in routine chest X-rays. This technology aimed to address critical gaps in lung cancer screening by improving the accuracy of incidental lung nodule detection and enabling broader community-wide screening, thereby facilitating earlier diagnosis and intervention for patients who might otherwise go undiagnosed until later stages.
VisiRad XR leveraged advanced machine learning and computer vision, demonstrating an 83% sensitivity in detecting lung nodules and masses in retrospective studies involving over 11,000 patient images. The software was designed to integrate seamlessly into existing radiology workflows, sending images with AI-detected lesions back to radiologists within their usual viewing setup for easy comparison and interpretation. This approach sought to enhance diagnostic capabilities, alleviate radiologist burnout due to increasing workloads, and ultimately improve patient outcomes by identifying lung cancer at more treatable stages.
**Important Note:** As of April 17, 2025, Imidex announced the sale of its FDA-cleared AI algorithm, VisiRad XR, along with its associated intellectual property and annotated dataset. The financial terms and the purchaser’s identity were not disclosed. This indicates a significant change in the operational status of Imidex as an independent developer and deployer of this specific technology.
Focus Areas
Business Intelligence
| Key Investors | Dr. Keith Hearon |
| Partnerships | Orbit Genomics (August 2024), Spesana (July 2024) |
| Acquisitions | Sale of its FDA-cleared AI algorithm VisiRad XR, intellectual property, and annotated dataset in April 2025. Purchaser undisclosed. |
| Technology | Google Cloud Vertex AI, machine learning, computer vision, V7 Darwin (for data labeling and workflows) |
| FDA Clearances | 1 cleared products (estimated) |
What Physicians Need to Know
For physicians, Imidex's VisiRad XR offers a significant advantage by augmenting diagnostic capabilities and improving patient care. Its FDA clearance and high sensitivity (83%) in detecting lung nodules on routine chest X-rays mean earlier identification of potential lung cancers, often at more treatable stages (Stage 1 or 2). This can lead to better patient outcomes and increased survival rates. The solution seamlessly integrates into existing radiology workflows, acting as an intelligent 'second-read' to help alleviate radiologist burnout and enhance accuracy, even for less experienced practitioners. By leveraging cost-effective chest X-rays, it enables broader population screening and incidental detection of lung nodules, reaching patients who might not undergo traditional CT screening.
Imidex's VisiRad XR is designed for seamless integration into existing radiology workflows and Picture Archiving and Communication Systems (PACS). It routes images with AI-detected lesions back to radiologists within their native viewing environment. The technology is built on the Google Cloud stack, including Google Vertex AI, Cloud Storage, and BigQuery, ensuring compliance, security, and robust infrastructure. Imidex has also partnered with companies like Spesana to integrate VisiRad XR into advanced medical data and clinical workflow platforms, enhancing the comprehensive nature of precision medicine by adding imaging diagnostics to molecular diagnostic capabilities.
What the Web Says
Imidex (also referred to as iMedX) appears to be a company with two distinct public profiles: one as a healthcare AI company focused on lung cancer detection, and another, more prominent one, as a medical transcription and coding service provider. Reviews for the healthcare AI company (Imidex) are generally positive, highlighting its innovative technology and potential to improve patient outcomes. In contrast, reviews for iMedX, the medical transcription and coding company, are largely negative, citing issues with pay, management, and work-life balance. It's important to differentiate between these two entities when evaluating feedback.
Overall: MixedStrengths
- Innovative AI technology for lung cancer detection (Imidex AI).
- Potential to improve early lung cancer diagnosis (Imidex AI).
- FDA-cleared AI solution (Imidex AI).
- Flexible work schedules for some roles (iMedX/medical transcription).
- Team-oriented environment (iMedX/medical transcription).
- Good customer support for their website (iMedix.com).
Limitations
- Poor pay and benefits (iMedX/medical transcription).
- Lack of job security and advancement opportunities (iMedX/medical transcription).
- Unhelpful and uncommunicative management (iMedX/medical transcription).
- Stressful work environment (iMedX/medical transcription).
- Inefficient software (iMedX/medical transcription).
- Work often sent overseas, leading to less work for employees (iMedX/medical transcription).
Based on reviews from: Indeed.com, REVIEWS.io, Comparably, G2, Capterra, PR Newswire
Last updated: 2026-07-18
Videos
News, demos, and interviews about Imidex.
Videos load interactively. If none appear, search YouTube for Imidex →
Press & Coverage
Frequently Asked Questions
Related Companies
Clarista is a healthcare AI company that focuses on building a “trust layer” for enterprise AI, particularly within regulated industries like healthcare and financial services. The company’s platform aims to address the challenges of data fragmentation, governance, and compliance that often hinder the successful implementation of AI projects in large organizations. Clarista’s technology unifies structured […]
HelloBooks.ai is an AI-powered accounting software company that aims to automate and simplify financial management for small businesses, freelancers, and accounting professionals. The platform utilizes generative AI to handle repetitive bookkeeping tasks such as transaction categorization, receipt capture, bank reconciliation, and report generation. It is designed to reduce manual data entry and improve accuracy, allowing […]
Vero, also known as Vero.ai, is an artificial intelligence company specifically designed to augment clinical workflows and improve patient care within the healthcare sector. Their primary focus is on leveraging AI to streamline administrative tasks, enhance diagnostic accuracy, and personalize treatment plans. By automating routine processes, Vero aims to free up healthcare professionals’ time, allowing […]
Ant Group, a global digital technology provider and operator of Alipay, has significantly expanded its focus into healthcare AI. The company recently upgraded its physician platform, Haodf for Doctor, into ‘AQ for Doctor,’ an AI-powered workstation designed to support physicians across various stages of clinical practice, including online consultations, patient management, clinical decision support, and […]
e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]
PayZen is a healthcare AI company dedicated to solving the healthcare affordability crisis for both patients and providers. The company’s AI-powered platform offers personalized, interest-free, and fee-free patient financing solutions, enabling patients to manage their medical bills through affordable payment plans tailored to their unique ability to pay. This approach aims to increase access to […]